RDHL
Redhill Biopharma Ltd.
stockNASDAQADR
At CloseOct 8, 2026 3:59:49 PM EDT
0.57USD+19.241%(+0.09)15,510,399
0.4800Bid0.6500Ask0.1700SpreadPre-marketOct 8, 2026 9:24:30 AM EDT
0.5194USD+9.578%(+0.0454)
After-hoursOct 8, 2026 4:59:30 PM EDT
0.55USD-2.689%(-0.02)
Loading…
Loading…
5.07M
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Dror Ben-Asher
HQ
Tel Aviv, Tel Aviv Yafo, Israel
113
Previous Close
$0.47
Beta
0.73
52-Week High
$2.14 2025-10-20
52-Week Low
$0.46 2026-10-01
SMA 50
$0.61
SMA 200
$0.87
Avg. Vol 10D
148,102
Avg. Vol 30D
3.81M
Avg. Vol 90D
1.40M
Relative Vol
4.00
8.89M
2.28M
25.66%
235,258
10.32%
1.00
46%/54%
40.80%
32.30%
90.7300%
250,000
284
96,612
736,481
Aug 20, 2024 · 1-for-25 (reverse)
RDHL Profile
redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise
RDHL Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.48 | 2026-10-01 | +18.79% | 3.409 |
| 1M | 0.65 | 2026-09-08 | -12.28% | 1.485 |
| 3M | 0.71 | 2026-07-08 | -19.69% | 0.408 |
| 6M | 0.80 | 2026-04-08 | -28.72% | -0.043 |
| 1Y | 1.82 | 2025-10-08 | -68.67% | 0.728 |
| 2Y | 8.01 | 2024-10-08 | -92.88% | — |
| 5Y | 4,900.00 | 2021-10-08 | -99.99% | 1.043 |
RDHL Stock Summary
Redhill Biopharma Ltd. (NASDAQ:RDHL) stock price today is $0.57, and today's volume is 15,252,645. RDHL is up 20.295% today. The 30 day average volume is 3.81M. RDHL market cap is $5.07M with 8.89M shares outstanding.